drugset / Trial / NCT05927272
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
Unknown
10 enrolled
University Hospital, Bordeaux
Centre National de la Recherche Scientifique, France · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to perform an in-depth analysis of the molecular pathways involved in lesions responding to current treatment and lesions not responding to current treatment
Timeline
- Start
- 2024-04-10
- Primary completion
- 2025-10-09
- Completion
- 2025-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Methylprednisolone | Other / unclassified | 16 mg | Oral |